Membership
Corporate Members
Abbott Laboratories
200 Abbott Park Road
Dept. 096K, Bldg. AP30-4
Abbott Park, IL 60064
847/938-6936, fax 847/935-8256
www.abbott.com
Abbott is a global, broad-based health care company devoted to discovering new medicines, new technologies, and new ways to manage health. The Abbott Pain Care portfolio includes well-known brands such as Vicodin®, Vicoprofen®, and Dilaudid®. Abbott Pain Care is also supported by a rich pipeline of novel therapeutics, including a controlled-release hydrocodone/acetaminophen product in Phase III clinical development.
Alpharma
One New England Avenue
Piscataway, NJ 08854
732/465-3600, fax 732/465-3630
www.alpharma.com
Alpharma Inc. (NYSE: ALO) is a global specialty pharmaceutical company with leadership positions in products for humans and animals. Alpharma is presently active in more than 80 countries. Alpharma has a growing branded pharmaceutical franchise in the U.S. pain market with its KADIAN® (morphine sulfate extended-release) Capsules, and an innovative pharmaceutical product pipeline that consists of several novel approaches to treat pain, including the FLECTOR® Patch (diclofenac epolamine topical patch), which was launched in January 2008. In addition, Alpharma is among the world's leading producers of several specialty pharmaceutical-grade bulk antibiotics and is internationally recognized as a leading provider of pharmaceutical products for poultry and livestock.
Ameritox
3510 North A Street
Bldg B, Suite 200
Midland, Texas 79705
866/926-9264 / fax 432/687-8598
www.ameritox.com
Ameritox is the nation’s leader in pain prescription monitoring. Only Ameritox offers RxGuardian, the most thorough and personalized lab report available. RxGuardian determines compliance based on prescription regimens. Peace of mind is provided to physicians by providing data to help ensure that patients are taking pain medications as prescribed.
Anesiva, Inc.
650 Gateway Boulevard
South San Francisco, CA 94080
650/624-9600, fax 650/624-7540
www.anesiva.com
Anesiva is a late-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for pain. Our pipeline includes Zingo™, a fast-acting, local anesthetic for analgesia prior to venipuncture and intravenous line placements; 4975, a long-lasting, non-opioid analgesic for site-specific, moderate-to-severe pain with near term focus on post-surgical pain and osteoarthritis pain.
Cephalon, Inc.
41 Moores Road
Frazer, PA 19355
610/344-0200, fax 610/344-0981
| Web sites | www.cephalon.com | |
| www.emergingsolutionsinpain.com | ||
Cephalon's Pain Care Franchise includes therapies for breakthrough pain and muscle spasms. FENTORA® (fentanyl buccal tablet0 [C-II] is indicated for breakthrough pain in opioid-tolerant patients with cancer. AMRIX® (Cyclobenxaprine Hydrochloride Extended-Release Tablets), the only once-daily skeletal muscle relaxant, is indicated for muscle spasm associated with acute, painful musculoskeletal conditions.
Durect Corporation
2 Results Way
Cupertino, CA 95014
408/777-1417, fax 408/777-3577
www.durect.com
DURECT is a specialty pharmaceutical company developing innovative drugs for pain and other chronic diseases, with late-stage development programs, Remoxy, POSIDUR, ELADUR, and Transdur Sufentanil. Durect's proprietary (oral, transdermal, injectable and implantable depot) delivery technologies enable the development of products with new indications and superior clinical and commercial attributes such as abuse deterrence, improved convenience, compliance, efficacy, and safety for small molecule and biologic drugs.
Elan Pharmaceuticals, Inc.
800 Gateway Blvd.
So. San Francisco, CA 94080
650/877-0900, fax 650/877-8370
www.elan.com
Elan Corporation, plc is a neuroscience-based biotechnology company committed to making a difference in the lives of patients and their families by dedicating ourselves to bringing innovations in science to fill significant unmet medical needs that continue to exist around the world. Elan currently sells PRIALT® (ziconotide intrathecal infusion) for patients with severe chronic pain.
Endo Pharmaceuticals Inc.
100 Endo Boulevard
Chadds Ford, PA 19317
610/558-9800, fax 610/558-4162
| Web sites | www.endo.com | |
| www.endopromise.com | ||
Endo Pharmaceuticals is a specialty pharmaceutical company with leadership in pain management and a balanced focus in complementary therapeutic areas. Endo is committed to advancing the care of pain patients through strong research and development programs, innovative technology and delivery systems, collaborative medical education initiatives, and unparalleled customer service.
Forest Laboratories, Inc.
909 Third Avenue
New York, NY 10022-4731
212/224-6806, fax 212/750-9152
www.frx.com
Forest Laboratories is a U.S.-based pharmaceutical company dedicated to identifying, developing, and delivering products that make a positive difference in people's lives. For more information, visit www.frx.com.
GlaxoSmithKline
3 Franklin Plaza, P. O. Box 13619
Philadelphia, PA 19101
215/751-7498
www.gsk.com
GlaxoSmithKline, one of the world's leading research-based pharmaceutical and healthcare companies, is committed to improving the quality of human life by enabling people to do more, feel better and live longer.
InSet Technologies Incorporated
500 International Drive
Mt. Olive, NJ 07828
973/426-9229, fax 973/426-0035
www.insetinc.com
InSet Technologies (www.insetinc.com) is focused on developing better treatment options for the 75 million Americans in chronic pain, more than diabetes, heart disease, and cancer combined. Our first product for delivery of Intrathecal medication, the Prometra® programmable implantable pump, is undergoing clinical trials. InSet is headquartered in Mount Olive, NJ.
King Pharmaceuticals, Inc.
400 Crossing Blvd.
Bridgewater, NJ 08807
908/429-6000, fax 908/927-8423
www.kingpharm.com
King Pharmaceuticals, Inc., headquartered in Bristol, Tennessee, is a vertically integrated company that develops, manufactures, markets and sells branded prescription pharmaceutical products. King, an S&P 500 Index company, seeks to identify promising opportunities in the pharmaceutical industry through development, in-licensing arrangements, and the strategic acquisition of branded products that can benefit from focused promotion, marketing and product life-cycle management.
Eli Lilly and Company
Lilly Corporate Center
Indianapolis, IN 46285
317/276-2000
www.lilly.com
Lilly is a leading innovation-driven pharmaceutical corporation. We're developing best-in-class pharmaceutical products by applying the latest research from our own worldwide laboratories and from collaborations with well-known scientific organizations. We're seeking answers for some of the world's most urgent medical needs. As our products save and improve lives, they also save overall health care costs: they are often less expensive than other forms of health care, such as surgery and hospitalization.
Medtronic
710 Medtronic Parkway
Minneapolis, MN 55432-5604
U.S.A.
Toll Free: 800/328-0810
763/505-5000, fax 763/505-1000
www.medtronic.com
Medtronic is the global leader in medical technology - alleviating pain, restoring health and extending life for millions of people around the world. Medtronic Neuromodulation provides innovative implantable neurostimulation and drug delivery devices to therapeutically treat intractable pain, as well as other chronic diseases and neurological disorders.
Merck & Co., Inc.
351 N. Sumneytown Pike
UG3A-20
North Wales, PA 19454-2505
267/305-9089, fax 267/305-1266
www.merck.com
Merck & Co., Inc. with corporate headquarters in Whitehouse Station, NJ, is a leading research-driven pharmaceutical products and services company. Merck discovers, develops, manufactures, and markets a broad range of innovative products to improve human and animal health.
NeurogesX, Inc.
2215 Bridgepointe Parkway, Suite 200
San Mateo, CA 94404
650/508-2116, fax 650/649-1798
www.neurogesx.com
NeurogesX is a biopharmaceutical company based in the San Francisco Bay Area. Our focus is on the development of effective treatments that relieve chronic pain and improve quality of life. Our leading product candidate, NGX-4010, has the potential to revolutionize the treatment of neuropathic pain because a single application may potentially provide months of relief.
Pain Therapeutics, Inc
416 Browning Way
South San Francisco, CA 94080
650/624-8200, fax 650/624-8222
www.paintrials.com
Pain Therapeutics is a biopharmaceutical company that develops novel drugs for pain management and oncology. We have three investigational pain drug candidates in clinical programs. Remoxy™ and PTI-202 are proprietary, abuse-resistant forms of opioid drugs. Oxytrex™ is a novel, next-generation painkiller that potentially offers less physical dependence than currently marketed opioid painkillers.
Pfizer Inc.
235 East 42nd Street
New York, NY 10017
212/573-7906, fax 212/885-1134
www.pfizer.com
Founded in 1849, Pfizer is the world's largest research-based pharmaceutical company taking new approaches to better health. Pfizer discovers and develops innovative medicines to treat and help prevent disease for both people and animals. We also partner with healthcare providers, governments and local communities around the world to expand access to our medicines and to provide better quality health care and health system support.
Premier Research
Centre Square West
1500 Market Street
Suite 3500
Philadelphia, PA 19102
727/865-0803, fax 215/282-5528
www.premier-research.com
Premier Research is recognized as an industry leader in clinical research for acute and chronic pain, having managed more than 300 analgesia trials treating more than 80,000 patients. We have conducted some of the largest and most important drug trials in pain in multicenter trials around the world and at our SCIREX Research Center in the United States.
PriCara, Unit of Ortho-McNeil, Inc.
1000 Route 202
Raritan, NJ 08869-0602
908/927-7639, fax 908/429-4163
Purdue Pharma L.P.
One Stamford Forum
201 Tresser Boulevard
Stamford, CT 06901-3431
203/588-8000, fax 203/588-8850
| Web sites | www.purduepharma.com | |
| www.partnersagainstpain.com | ||
Purdue Pharma L.P. is dedicated to finding, developing, and bringing to market new medicines and related products that improve health outcomes. The company has led the battle against inadequate treatment of pain by developing sustained-release medications to manage pain and provide meaningful benefits for patients. In 1993, Purdue established Partners Against Pain® as a resource to help patients, caregivers, and healthcare professionals advance standards of pain care and alleviate unnecessary suffering through education and advocacy.
Solstice Neurosciences, Inc.
40 General Warren Blvd., Suite 160
Melvern, PA 19355
267/620-8000, fax 267/620-8190
www.solsticeneuro.com
UCB, Brussels, Belgium
UCB, Brussels, Belgium is a global leader in the biopharmaceutical industry dedicated to the research, development and commercialisation of innovative pharmaceutical and biotechnology products in the fields of central nervous system disorders, allergy/respiratory diseases, immune and inflammatory disorders and oncology—UCB focuses on securing a leading position in severe disease categories. Employing more than 10,000 people in over 40 countries, UCB achieved revenue of 3.5 billion euro in 2006 on a pro forma basis. UCB is listed on the Euronext Brussels Exchange and owns approx. 88% of the shares of SCHWARZ PHARMA AG. SCHWARZ PHARMA AG (Monheim, Germany) is a member of UCB Group.